photo
S H Aaltomaa

Urological Clinics, Kuopio University Hospital, Kuopio, Finland.


1
S Aaltomaa, V Kärjä, S Kainulainen “Secondary squamous cell prostate cancer after prostate brachytherapy treatment.”, Scand. J. Urol. Nephrol., vol. 45, no. 5, 2011
View At Pubmed
2
Sirpa H Aaltomaa, Vesa V Kataja, Atte Räty, Jan-Erik Palmgren, Tapani Lahtinen “Does the outcome of prostate cancer patients with large prostates differ from small prostate size in permanent seed, low dose-rate brachytherapy?”, Scand. J. Urol. Nephrol., vol. 45, no. 5, 2011
View At Pubmed
3
Sirpa H Aaltomaa, Vesa V Kataja, Tapani Lahtinen, Jan-Erik Palmgren, Tapio Forsell “Eight years experience of local prostate cancer treatment with permanent I125 seed brachytherapy--morbidity and outcome results.”, Radiother Oncol, vol. 91, no. 2, 2009
View At Pubmed
4
S Aaltomaa, V Kärjä, P Lipponen, T Isotalo, J P Kankkunen, M Talja, R Mokka “Expression of Ki-67, cyclin D1 and apoptosis markers correlated with survival in prostate cancer patients treated by radical prostatectomy.”, Anticancer Res., vol. 26, no. 6C, 2007
View At Pubmed
5
S Aaltomaa, V Kärjä, P Lipponen, T Isotalo, J P Kankkunen, M Talja, R Mokka “Reduced alpha- and beta-catenin expression predicts shortened survival in local prostate cancer.”, Anticancer Res., vol. 25, no. 6C, 2005
View At Pubmed
6
Sirpa Aaltomaa, Pertti Lipponen, Vesa Kärjä, Seppo Lundstedt, Jani Lappi, Veli-Matti Kosma “The expression and prognostic value of alpha-, beta- and gamma-catenins in renal cell carcinoma.”, Anticancer Res., vol. 24, no. 4, 2004
View At Pubmed
7
S Aaltomaa, P Lipponen, R Tammi, M Tammi, J Viitanen, J-P Kankkunen, V-M Kosma “Strong Stromal Hyaluronan Expression Is Associated with PSA Recurrence in Local Prostate Cancer.”, Urol. Int., vol. 69, no. 4, 2002
View At Pubmed
8
S Aaltomaa, P Lipponen, J Viitanen, J P Kankkunen, M Ala-Opas, V M Kosma “Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy.”, Eur. Urol., vol. 38, no. 5, 2001
View At Pubmed
9
S Aaltomaa, P Lipponen, M Ala-Opas, V M Kosma “Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer.”, Eur. Urol., vol. 39, no. 2, 2001
View At Pubmed
10
S Aaltomaa, M Ala-Opas “The effect of transurethral needle ablation on symptoms of chronic pelvic pain syndrome--a pilot study.”, Scand. J. Urol. Nephrol., vol. 35, no. 2, 2001
View At Pubmed
11
S H Aaltoma, P K Lipponen, V M Kosma “Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer.”, Anticancer Res., vol. 21, no. 4B, 2001
View At Pubmed
12
S H Aaltomaa, P K Lipponen, J Viitanen, J P Kankkunen, M Y Ala-Opas, V M Kosma “The prognostic value of inducible nitric oxide synthase in local prostate cancer.”, BJU Int., vol. 86, no. 3, 2000
View At Pubmed

No Biography Available.